Taylor L, Crockett J, Tayo B, Morrison G. A Phase 1, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment. J Clin Pharmacol. 2019;59(8):1110-1119. View abstract.
Pretzsch CM, Freyberg J, Voinescu B, et al. Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder. Neuropsychopharmacology. 2019;44(8):1398-1405. View abstract.
Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R., Sanvito, W. L., Lander, N., and Mechoulam, R. Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology 1980;21(3):175-185. View abstract.
Trembly B, Sherman M. Double-blind clinical study of cannabidiol as a secondary anticonvulsant. Marijuana ’90 International Conference on Cannabis and Cannabinoids 1990;2:5.
Consroe P, Wolkin A. Cannabidiol-antiepilpetic drug comparisons and interactions in experimentally induced seizures in rats. J Pharmacol Exp Ther 1977;201(1):26-32. View abstract.
Appiah-Kusi E, Petros N, Wilson R, et al. Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis. Psychopharmacology (Berl). 2020 Jan 8. View abstract.
Yamaori S, Maeda C, Yamamoto I, Watanabe K. Differential inhibition of human cytochrome P450 2A6 and 2B6 by major phytocannabinoids. Forensic Toxicol 2011;29:117-24.
Scientific studies to date have shown that CBD can help lower blood pressure. In a 2017 study conducted by the American Society for Clinical Investigation and published in the journal JCI Insight, researchers gave a group of subjects a dose of either 600 milligrams of CBD or a placebo. They then put subjects through a number of tests, analyzing blood pressure and other related body processes. Ultimately, they found that CBD reduced blood pressure levels compared with the placebo.
Of course, other factors could complicate the effects of CBD and could be responsible for adverse reactions. For example, adverse effects could stem from an interaction between CBD and the patient’s existing medications.
Interestingly, CBD has made significant headway into pet products. According to a PR Newswire report that circulated in early 2019, pet and animal product sales are expected to reach $125 million by 2022, making the sector one of the fastest-growing in the CBD market.
Other factors, such as an interaction between CBD and the patient’s existing medications, could complicate the effects of CBD and could be responsible for adverse reactions. Photo by: Gina Coleman/Weedmaps
One such study was published in 2013 in the journal Current Drug Abuse Review as researchers reported on a phenomenon called Cannabinoid Hyperemesis Syndrome. This newly identified clinical syndrome coincides with chronic cannabis abuse and frequent episodes of nausea and vomiting, according to the authors of the study, all of whom are physicians. The researchers classified the prevalence of the syndrome as unknown, so further studies are needed to understand if such side effects are rare.
Regardless of the CBD product you’re taking, the answer is still the same. If you’re wondering, “Can you overdose on CBD gummies?”, the answer is no. When you eat a CBD gummy, your body will metabolize the CBD differently than it will if you smoke or vape CBD. While this could change how long it takes the CBD to go into effect or how long the effects last, it won’t change the toxicity of CBD.
Cannabidiol (CBD) has become one of the most popular products in the entire cannabis industry, showing up in local coffee shops, pharmacies, and legal marijuana dispensaries. Despite the explosive popularity of CBD, there is still a lot of confusion about what CBD is and how it affects humans. For example, some may wonder: Can you overdose on CBD?